Solve Therapeutics Raises $120 Million to Develop Best-in-Class ADCs for Solid Tumors

SAN DIEGO–(BUSINESS WIRE)– #ADC–Solve Therapeutics Raises $120 Million to Develop Best-in-Class ADCs for Solid Tumors
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks